205 related articles for article (PubMed ID: 26648722)
21. Low molecular weight linear polyethylenimine-b-poly(ethylene glycol)-b-polyethylenimine triblock copolymers: synthesis, characterization, and in vitro gene transfer properties.
Zhong Z; Feijen J; Lok MC; Hennink WE; Christensen LV; Yockman JW; Kim YH; Kim SW
Biomacromolecules; 2005; 6(6):3440-8. PubMed ID: 16283777
[TBL] [Abstract][Full Text] [Related]
22. In Vitro Drug and Gene Delivery Using Random Cationic Copolymers Forming Stable and pH-Sensitive Polymersomes.
Laskar P; Dey J; Banik P; Mandal M; Ghosh SK
Macromol Biosci; 2017 Apr; 17(4):. PubMed ID: 27879056
[TBL] [Abstract][Full Text] [Related]
23. Mitomycin C-soybean phosphatidylcholine complex-loaded self-assembled PEG-lipid-PLA hybrid nanoparticles for targeted drug delivery and dual-controlled drug release.
Li Y; Wu H; Yang X; Jia M; Li Y; Huang Y; Lin J; Wu S; Hou Z
Mol Pharm; 2014 Aug; 11(8):2915-27. PubMed ID: 24984984
[TBL] [Abstract][Full Text] [Related]
24. Design of polyethylene glycol-polyethylenimine nanocomplexes as non-viral carriers: mir-150 delivery to chronic myeloid leukemia cells.
Biray Avcı Ç; Özcan İ; Balcı T; Özer Ö; Gündüz C
Cell Biol Int; 2013 Nov; 37(11):1205-14. PubMed ID: 23881828
[TBL] [Abstract][Full Text] [Related]
25. Effect of polyethylene glycol (PEG) chain organization on the physicochemical properties of poly(D, L-lactide) (PLA) based nanoparticles.
Essa S; Rabanel JM; Hildgen P
Eur J Pharm Biopharm; 2010 Jun; 75(2):96-106. PubMed ID: 20211727
[TBL] [Abstract][Full Text] [Related]
26. [Application of orthogonal design in optimization of the transfection efficiency of polyethylenimine mediated gene transfer to hepatoma carcinoma cells].
Zhou Y; Chen X; Ye M; Shuai X; Deng Y
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Feb; 28(1):104-9. PubMed ID: 21485194
[TBL] [Abstract][Full Text] [Related]
27. Development and characterization of an improved formulation of cholesteryl oleate-loaded cationic solid-lipid nanoparticles as an efficient non-viral gene delivery system.
Limeres MJ; Suñé-Pou M; Prieto-Sánchez S; Moreno-Castro C; Nusblat AD; Hernández-Munain C; Castro GR; Suñé C; Suñé-Negre JM; Cuestas ML
Colloids Surf B Biointerfaces; 2019 Dec; 184():110533. PubMed ID: 31593829
[TBL] [Abstract][Full Text] [Related]
28. Anthocyanins encapsulated by PLGA@PEG nanoparticles potentially improved its free radical scavenging capabilities via p38/JNK pathway against Aβ
Amin FU; Shah SA; Badshah H; Khan M; Kim MO
J Nanobiotechnology; 2017 Feb; 15(1):12. PubMed ID: 28173812
[TBL] [Abstract][Full Text] [Related]
29. Tumor targeting and microenvironment-responsive nanoparticles for gene delivery.
Huang S; Shao K; Kuang Y; Liu Y; Li J; An S; Guo Y; Ma H; He X; Jiang C
Biomaterials; 2013 Jul; 34(21):5294-302. PubMed ID: 23562171
[TBL] [Abstract][Full Text] [Related]
30. Preparation and Characterization of Cationic PLA-PEG Nanoparticles for Delivery of Plasmid DNA.
Zou W; Liu C; Chen Z; Zhang N
Nanoscale Res Lett; 2009 May; 4(9):982-992. PubMed ID: 20596550
[TBL] [Abstract][Full Text] [Related]
31. Insight into the role of physicochemical parameters in a novel series of amphipathic peptides for efficient DNA delivery.
Sharma R; Shivpuri S; Anand A; Kulshreshtha A; Ganguli M
Mol Pharm; 2013 Jul; 10(7):2588-600. PubMed ID: 23725377
[TBL] [Abstract][Full Text] [Related]
32. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
Essa S; Rabanel JM; Hildgen P
Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
[TBL] [Abstract][Full Text] [Related]
33. PEGylated poly(2-(dimethylamino) ethyl methacrylate)/DNA polyplex micelles decorated with phage-displayed TGN peptide for brain-targeted gene delivery.
Qian Y; Zha Y; Feng B; Pang Z; Zhang B; Sun X; Ren J; Zhang C; Shao X; Zhang Q; Jiang X
Biomaterials; 2013 Mar; 34(8):2117-29. PubMed ID: 23245924
[TBL] [Abstract][Full Text] [Related]
34. Characterization of PLL-g-PEG-DNA nanoparticles for the delivery of therapeutic DNA.
Rimann M; Lühmann T; Textor M; Guerino B; Ogier J; Hall H
Bioconjug Chem; 2008 Feb; 19(2):548-57. PubMed ID: 18173226
[TBL] [Abstract][Full Text] [Related]
35. Characterization of long-circulating cationic nanoparticle formulations consisting of a two-stage PEGylation step for the delivery of siRNA in a breast cancer tumor model.
Ho EA; Osooly M; Strutt D; Masin D; Yang Y; Yan H; Bally M
J Pharm Sci; 2013 Jan; 102(1):227-36. PubMed ID: 23132529
[TBL] [Abstract][Full Text] [Related]
36. Ternary nanoparticles composed of cationic solid lipid nanoparticles, protamine, and DNA for gene delivery.
He SN; Li YL; Yan JJ; Zhang W; Du YZ; Yu HY; Hu FQ; Yuan H
Int J Nanomedicine; 2013; 8():2859-69. PubMed ID: 23990715
[TBL] [Abstract][Full Text] [Related]
37. Optimization of in vivo DNA delivery with NickFect peptide vectors.
Freimann K; Arukuusk P; Kurrikoff K; Vasconcelos LDF; Veiman KL; Uusna J; Margus H; Garcia-Sosa AT; Pooga M; Langel Ü
J Control Release; 2016 Nov; 241():135-143. PubMed ID: 27664329
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of polyethylene glycol (PEG)-modified cationic liposome-mediated gene deliveries: effects on serum stability and transfection efficiency.
Kim JK; Choi SH; Kim CO; Park JS; Ahn WS; Kim CK
J Pharm Pharmacol; 2003 Apr; 55(4):453-60. PubMed ID: 12803766
[TBL] [Abstract][Full Text] [Related]
39. Stabilized integrin-targeting ternary LPD (lipopolyplex) vectors for gene delivery designed to disassemble within the target cell.
Mustapa MF; Grosse SM; Kudsiova L; Elbs M; Raiber EA; Wong JB; Brain AP; Armer HE; Warley A; Keppler M; Ng T; Lawrence MJ; Hart SL; Hailes HC; Tabor AB
Bioconjug Chem; 2009 Mar; 20(3):518-32. PubMed ID: 19228071
[TBL] [Abstract][Full Text] [Related]
40. Defining the drug incorporation properties of PLA-PEG nanoparticles.
Govender T; Riley T; Ehtezazi T; Garnett MC; Stolnik S; Illum L; Davis SS
Int J Pharm; 2000 Apr; 199(1):95-110. PubMed ID: 10794931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
